Rating History for Pacira Pharmaceuticals (PCRX) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for PCRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/1/2026 Douglas Tsao Maintain Buy
(Buy)		 38.00
(N/A)		  
 		   Details